Delivery Order SPE2DB24D1104-SPE2DB25FYDX2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Betamethasone SP-AC 30 mg/5 ml in 5 ml vials, with a ceiling value of $1,179.45 and a firm fixed price structure. This delivery order is non-set-aside and competitively awarded, with an ultimate completion date of August 4, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, leveraging the company's extensive pharmaceutical...
- The Defense Logistics Agency awarded a $1,573.10 delivery order to AmerisourceBergen Drug Corp for Betamethasone SP-AC 30 mg/5 ml on August 21, 2025, with completion targeted for August 22, 2025. This non-set-aside contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Betamethasone SP-AC 30 mg/5 ml in 5 ml vials. This contract, valued at $42,340.61, represents a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The ultimate completion date is set for September 4, 2025, with performance occurring at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $7,771.69 to AmerisourceBergen Drug Corp for Betamethasone SP-AC 30 mg/5 ml (5 ml vials). The contract, awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed from the company's location in Conshohocken, Pennsylvania. This order represents a routine pharmaceutical...
- On August 11, 2025, the Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Betamethasone SP-AC 30 mg/5 ml vials with a ceiling value of $27,745.17. This firm fixed-price delivery order, which must be completed by August 12, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Betamethasone SP-AC 30 mg/5 ml 5 ml medication. The contract has a firm fixed price of $1,174.93 and a period of performance through April 30, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,979.20, is for the delivery of Betamethasone SP-AC 30 mg/5 ml, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with a performance period through May 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,883.43 firm-fixed-price contract is for the delivery of betamethasone sodium phosphate, a corticosteroid medication, with a performance period through March 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,798.55 firm fixed-price delivery order is for the supply of Betamethasone SP-AC 30 MG/5 ML 5ML, a medical product. The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of BETAMETHASONE SP-AC 30 MG/5 ML 5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price of $3,530.66 and a completion date of June 9, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This contract is not a set-aside and was awarded on June 6, 2025. Additionally, Amerisourcebergen Drug...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYDX2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,010.16 to AmerisourceBergen Drug Corp for Betamethasone SP-AC 30 mg/5 mL (5 mL vials) on July 30, 2025, with completion scheduled for July 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's comprehensive $999.99 billion IDC with DLA Troop Support Medical (SPE2DX), which runs through December 2026 and serves as a global pharmaceutical support vehicle for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated consistent capability to fulfill federal medical procurement requirements through competitive awards across its extensive portfolio of generic and brand-name medications, vaccines, and specialized medical supplies supporting military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/30/25 |